So, not COVID related, however, this is WONDERFUL news. Only in Phase I trials, but 97% of participants generated an antibody response against HIV! That is ASTOUNDING. Collaborators here are partnering with Moderna to develop an mRNA-based candidate! https://t.co/sHxHe6wFLz

— Chise 🔜 FWA (@sailorrooscout) April 3, 2021